-
Biosimilar path to take form by patent cliff
It’s hard to disagree that generic drug companies have had a good run for the last several years. Branded drug companies developed a large number of drugs that proved highly effective at treating widespread medical conditions and became blockbusters, garnering billions of dollars in sales in the United States alone. As patents on these blockbuster drugs have expired, they’ve provided generic manufacturers with enormous revenues, helping some to join the ranks of the world’s biggest drug companies.
-
HHS, AT&T partner on mobile diabetes self-management program
WASHINGTON — The Department of Health and Human Services' Office of Minority Health, the American Association of Diabetes Educators and AT&T on Monday announced an initiative to evaluate the use of mobile devices to deliver diabetes self-management training within an underserved minority community in Dallas.